Dr. Tejwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
39450 W 12 Mile Rd
Novi, MI 48377Phone+1 800-436-7936Fax+1 248-344-6699
Education & Training
- Beaumont Hospital, Royal OakFellowship, Medical Oncology, 1985 - 1986
- Detroit Medical Center/Wayne State University (Sinai Grace)Residency, Internal Medicine, 1984 - 1985
- Detroit Medical Center/Wayne State University (Sinai Grace)Residency, Internal Medicine, 1982 - 1982
- Detroit Medical Center/Wayne State University (Sinai Grace)Residency, Internal Medicine, 1981 - 1981
- Maulana Azad Medical CollegeClass of 1973
Certifications & Licensure
- MI State Medical License 1984 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 417 citationsIpilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II studySusan F. Slovin, Celestia S. Higano, Omid Hamid, Sheela Tejwani, Andrea L. Harzstark
Annals of Oncology. 2013-07-01 - 31 citationsClinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Cli...Ulka N. Vaishampayan, Lance K. Heilbrun, Paul Monk, Sheela Tejwani, Guru Sonpavde
JAMA Network Open. 2021-01-04 - 447 citationsCirculating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobagyi, Eric P. Winer, Brian Leyland-Jones
Journal of Clinical Oncology. 2014-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: